Health Care: Drugs

AstraZeneca PLC (AZN: NYSE)

$71.69 n/a | n/a%
12/19/14 - 04:04 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 25.71B 27.97B 33.59B 33.27B
Cost of Sales 678.00M 2.88B 3.48B 3.65B
Gross Operating Profit 25.03B 25.10B 30.12B 29.62B
Selling, General, and Administrative Expenses 12.51B 10.16B 11.51B 10.78B
Research & Development 4.82B 5.24B 5.52B 5.32B
Operating Income before D & A (EBITDA) 7.70B 9.70B 13.08B 13.52B
Depreciation & Amortization 4.58B 2.52B 2.55B 2.74B
Interest Income 50.00M 528.00M 552.00M 516.00M
Other Income - Net 595.00M 970.00M 0.00 712.00M
Special Income / Charges 0.00 0.00 2.26B 0.00
Total Income Before Interest Expenses (EBIT) 3.76B 8.68B 13.35B 12.01B
Interest Expense 495.00M 958.00M 980.00M 1.03B
Pre-Tax Income 3.27B 7.72B 12.37B 10.98B
Income Taxes 696.00M 1.39B 2.35B 2.90B
Minority Interest 15.00M 30.00M 33.00M 28.00M
Net Income From Continuing Operations 2.57B 6.33B 10.02B 8.08B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 2.57B 6.33B 10.02B 8.08B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 2.56B 6.30B 9.98B 8.05B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.57B 6.33B 7.76B 8.08B
Preferred Dividends
Net Income Available To Common 2.57B 6.33B 10.02B 8.08B
Basic EPS from Continuing Ops. 2.04 4.99 7.34 5.60
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 2.04 4.99 7.34 5.60
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 -0.01 0.00
Basic EPS, Total 2.04 4.99 7.33 5.60
Basic Normalized Net Income/Share 2.04 4.99 5.68 5.60
EPS fr Continuing Ops. 2.04 4.98 7.30 5.57
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 2.04 4.98 7.30 5.57
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 2.04 4.98 7.30 5.57
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.04 4.98 5.66 5.57
Dividends Paid per Share 2.80 2.85 2.70 2.41

Portfolios with AZN

Latest AZN Headlines from TheStreet

More Financial News for AZN

Press Releases for AZN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter